Impact of SPARC expression on treatment response of pembrolizumab and brain metastasis in patients with metastatic non-small cell lung cancer.

International immunopharmacology(2023)

引用 0|浏览4
暂无评分
摘要
Our study sheds light on a novel aspect of SPARC expression as a potential predictor of pembrolizumab response and a marker for CNS progression in metastatic NSCLC patients treated in the first-line setting.
更多
查看译文
关键词
Non-small cell lung cancer,SPARC expression,Pembrolizumab,Response
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要